| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 736.00K | — |
| Operating expense | — | — |
| Net income | 4.58M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MCRB returned -76.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -69.4% |
| 1 year | -76.5% |
| 5 years | -96.4% |
| 10 years | -97.8% |
| All-time high | $830.00 (Jun 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MCRB would be worth today ›No. Seres Therapeutics, Inc. has not paid a dividend in the past 12 months.
Seres Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol MCRB.
Seres Therapeutics, Inc. is part of the Healthcare sector.
Seres Therapeutics, Inc. has a market cap of 45.80M USD, based on the latest quote.
Seres Therapeutics, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
